beigene.com (BGNE) - Company Revenue

Corporate emblem and logo of beigene.com (BGNE)

BeiGene, Ltd. (BGNE) is a global biotech leader bridging Western and Chinese markets through robust R&D and the drug Brukinsa. The company's total commercial revenue on this chart reflects demand dynamics, with the metric holding around 6.63. Robotic bio-screening is accelerating drug discovery, which is critical amid fierce global competition and the struggle for patent protection.

BGNE BeiGene, Ltd.: Revenue and Sales Volume in the range 07/04/2022 - 11/17/2026

Comprehensive metric breakdowns and analytics for beigene.com (BGNE)

- market price and analyst price targets:
- market capitalization indicators:
Comprehensive company analysis:BeiGene, Ltd. BGNE
Mass-produced product of BeiGene, Ltd.

This metric aggregates daily revenue, allowing investors to track the actual speed of business expansion and identify hyper-growth phases prior to the publication of official financial statements. For BeiGene, Ltd. (BGNE), such granularity is critical as it reflects the adoption rates of innovative oncology drugs across global therapy centers, which is clearly evidenced by the company's gross sales volume dynamics through its scale of market capture.

Key competitors

Company Revenue ONC|Revenue and Sales Volume HALO|RVMD (Revolution Medicines, Inc.) - Company Sales Revenue|Company Revenue Ascentage Pharma Corp AAPG|Company Total Sales Volume CG Oncology, Inc.|URGN - Company Revenue|Bicara Therapeutics Inc. (BCAX) - Company Sales|Personalis Inc (PSNL) - Company Revenue|ERAS - Company Gross Revenue|DCTH (Delcath Systems Inc) - Revenue and Sales Volume|Company Revenue YMAB|Revenue and Sales Volume AURA|Company Revenue CADL (Candel)|Accuray, Inc. - Company Sales|SELLAS Life Sciences Group Inc. - Company Revenue|ACTU: Company Sales|Company Total Revenue Citius Oncology Inc|HURA: Revenue and Sales Volume|TARA: Company Total Sales|FATE (fatetherapeutics.com) - Revenue and Sales Volume|Company Sales Aadi Bioscience Inc (WHWK)|Revenue and Sales Volume TCRX|CSBR - Company Total Revenue|Revenue and Sales Volume XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Company Total Revenue|OSTX: Company Sales|Company Sales Revenue RADX (Radiopharm Theranostics)|Artiva (ARTV) - Company Revenue|ANL: Company Total Sales|VERU (Veru Corporation) - Revenue and Sales Volume|Company Total Revenue Tempest Therapeutics, Inc. TPST|Revenue and Sales Volume XLO|Renovaro - Company Sales Volume|Company Revenue Mural Bio MURA|KAPA: Company Sales Volume|OnKure Therapeutics - Revenue and Sales Volume|Company Gross Revenue w2.cytomed.sg GDTC|CRIS: Revenue and Sales Volume|Company Sales Apollomics Inc.|THAR (Tharimmune Corporation) - Revenue and Sales Volume|Revenue and Sales Volume Advanced Biomed Inc|Revenue and Sales Volume GNPX|Company Sales Calidi Biotherapeutics Inc. CLDI|Company Revenue Sunshine Biopharma Inc. SBFM|Company Gross Revenue Xenetic Biosciences (XBIO)|SLRX - Company Revenue|Company Total Revenue Kitov Pharma|AON (AONC) - Company Revenue|Company Sales checkpointtx.com|Company Revenue Elevation Oncology, Inc.|iCAD, Inc. (ICAD) - Company Gross Revenue|Company Revenue Ikena (IKNA)|NTBL - Company Total Revenue|Company Revenue viracta.com VIRX|morphosys.com (MOR) - Company Total Revenue|NAYA Biosciences Inc - Revenue and Sales Volume|AAPGV: Company Revenue